6lqg

Human gamma-secretase in complex with small molecule Avagacestat

spinqualitylabelsall models 6lqg, resolution 3.10Å Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image   Print3D Structural highlights 6lqg is a 4 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance. Method: Electron Microscopy, Resolution 3.1Å Ligands: BMA, CLR, EN9, NAG, PC1 Resources: FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT Disease NICA_HUMAN Hidradenitis suppurativa. The disease is caused by mutations affecting the gene represented in this entry. Function NICA_HUMAN Essential subunit of the gamma-secretase complex, an endoprotease complex that catalyzes the intramembrane cleavage of integral membrane proteins such as Notch receptors and APP (beta-amyloid precursor protein). It probably represents a stabilizing cofactor required for the assembly of the gamma-secretase complex. Publication Abstract from PubMed Development of gamma-secretase inhibitors (GSIs) and modulators (GSMs) represents an attractive therapeutic opportunity for Alzheimer's disease (AD) and cancers. However, how these GSIs and GSMs target gamma-secretase has remained largely unknown. Here, we report the cryoelectron microscopy (cryo-EM) structures of human gamma-secretase bound individually to two GSI clinical candidates, Semagacestat and Avagacestat, a transition state analog GSI L685,458, and a classic GSM E2012, at overall resolutions of 2.6-3.1 A. Remarkably, each of the GSIs occupies the same general location on presenilin 1 (PS1) that accommodates the beta strand from amyloid precursor protein or Notch, interfering with substrate recruitment. L685,458 directly coordinates the two catalytic aspartate residues of PS1. E2012 binds to an allosteric site of gamma-secretase on the extracellular side, potentially explaining its modulating activity. Structural analysis reveals a set of shared themes and variations for inhibitor and modulator recognition that will guide development of the next-generation substrate-selective inhibitors. Structural basis of gamma-secretase inhibition and modulation by small molecule drugs.,Yang G, Zhou R, Guo X, Yan C, Lei J, Shi Y Cell. 2021 Jan 21;184(2):521-533.e14. doi: 10.1016/j.cell.2020.11.049. Epub 2020 , Dec 28. PMID:33373587 From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See Also Gamma secretase

Proteopedia Page Contributors and Editors (what is this?)

OCA